MedTrace Logo

Garmin PACT (Physical Activity Tracking in Type 1 Diabetes Using Garmin Vivosmart)

NCT05992350 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2025-10-17

Study results available
· View outcomes & findings →

Summary

The goal of this observational study is to test the Garmin Vivosmart in children and youth (8-21) with Type 1 Diabetes (T1D) and their parents. The main questions it aims to answer are:

* Does the Garmin Vivosmart increase physical activity (PA)?
* Does the Garmin Vivosmart improve T1D status

Participants will:

* Wear the Garmin Vivosmart (4 or higher) for a year
* Complete surveys at the beginning, middle and end of participation asking about your T1D, T1D management, and PA
* Parents of children will also complete similar surveys about T1D

Conditions

Interventions

OTHER

Garmin physical activity tracker

The Garmin physical activity tracker is worn like a watch on the user. The tracker assesses several physical states, indicates when the body is at optimal time for activity or when the body needs to rest. The tracker also monitors stress levels and prompts relaxation when appropriate. The tracker sets goals with participants based on previously completed activity. The tracker alerts participants after a period of inactivity, encourages regular movement throughout the day, and decreases the amount of time spent sedentary.

Sponsors & Collaborators

  • Children's Mercy Hospital Kansas City

    lead OTHER

Principal Investigators

  • Mark Clements, MD · Children's Mercy

Eligibility

Min Age
8 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-16
Primary Completion
2025-06-18
Completion
2025-06-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05992350 on ClinicalTrials.gov